OTC Anti-Infective Medications Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Anti-Infective Medications Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Antifungals
1.2.3 Antiseptic
1.2.4 Antiparasitics
1.3 Market by Application
1.3.1 Global OTC Anti-Infective Medications Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 E-Commerce
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global OTC Anti-Infective Medications Market Perspective (2017-2028)
2.2 OTC Anti-Infective Medications Growth Trends by Region
2.2.1 OTC Anti-Infective Medications Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 OTC Anti-Infective Medications Historic Market Size by Region (2017-2022)
2.2.3 OTC Anti-Infective Medications Forecasted Market Size by Region (2023-2028)
2.3 OTC Anti-Infective Medications Market Dynamics
2.3.1 OTC Anti-Infective Medications Industry Trends
2.3.2 OTC Anti-Infective Medications Market Drivers
2.3.3 OTC Anti-Infective Medications Market Challenges
2.3.4 OTC Anti-Infective Medications Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Anti-Infective Medications Players by Revenue
3.1.1 Global Top OTC Anti-Infective Medications Players by Revenue (2017-2022)
3.1.2 Global OTC Anti-Infective Medications Revenue Market Share by Players (2017-2022)
3.2 Global OTC Anti-Infective Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by OTC Anti-Infective Medications Revenue
3.4 Global OTC Anti-Infective Medications Market Concentration Ratio
3.4.1 Global OTC Anti-Infective Medications Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Anti-Infective Medications Revenue in 2021
3.5 OTC Anti-Infective Medications Key Players Head office and Area Served
3.6 Key Players OTC Anti-Infective Medications Product Solution and Service
3.7 Date of Enter into OTC Anti-Infective Medications Market
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Anti-Infective Medications Breakdown Data by Type
4.1 Global OTC Anti-Infective Medications Historic Market Size by Type (2017-2022)
4.2 Global OTC Anti-Infective Medications Forecasted Market Size by Type (2023-2028)
5 OTC Anti-Infective Medications Breakdown Data by Application
5.1 Global OTC Anti-Infective Medications Historic Market Size by Application (2017-2022)
5.2 Global OTC Anti-Infective Medications Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America OTC Anti-Infective Medications Market Size (2017-2028)
6.2 North America OTC Anti-Infective Medications Market Size by Type
6.2.1 North America OTC Anti-Infective Medications Market Size by Type (2017-2022)
6.2.2 North America OTC Anti-Infective Medications Market Size by Type (2023-2028)
6.2.3 North America OTC Anti-Infective Medications Market Share by Type (2017-2028)
6.3 North America OTC Anti-Infective Medications Market Size by Application
6.3.1 North America OTC Anti-Infective Medications Market Size by Application (2017-2022)
6.3.2 North America OTC Anti-Infective Medications Market Size by Application (2023-2028)
6.3.3 North America OTC Anti-Infective Medications Market Share by Application (2017-2028)
6.4 North America OTC Anti-Infective Medications Market Size by Country
6.4.1 North America OTC Anti-Infective Medications Market Size by Country (2017-2022)
6.4.2 North America OTC Anti-Infective Medications Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe OTC Anti-Infective Medications Market Size (2017-2028)
7.2 Europe OTC Anti-Infective Medications Market Size by Type
7.2.1 Europe OTC Anti-Infective Medications Market Size by Type (2017-2022)
7.2.2 Europe OTC Anti-Infective Medications Market Size by Type (2023-2028)
7.2.3 Europe OTC Anti-Infective Medications Market Share by Type (2017-2028)
7.3 Europe OTC Anti-Infective Medications Market Size by Application
7.3.1 Europe OTC Anti-Infective Medications Market Size by Application (2017-2022)
7.3.2 Europe OTC Anti-Infective Medications Market Size by Application (2023-2028)
7.3.3 Europe OTC Anti-Infective Medications Market Share by Application (2017-2028)
7.4 Europe OTC Anti-Infective Medications Market Size by Country
7.4.1 Europe OTC Anti-Infective Medications Market Size by Country (2017-2022)
7.4.2 Europe OTC Anti-Infective Medications Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Anti-Infective Medications Market Size (2017-2028)
8.2 Asia-Pacific OTC Anti-Infective Medications Market Size by Type
8.2.1 Asia-Pacific OTC Anti-Infective Medications Market Size by Type (2017-2022)
8.2.2 Asia-Pacific OTC Anti-Infective Medications Market Size by Type (2023-2028)
8.2.3 Asia-Pacific OTC Anti-Infective Medications Market Share by Type (2017-2028)
8.3 Asia-Pacific OTC Anti-Infective Medications Market Size by Application
8.3.1 Asia-Pacific OTC Anti-Infective Medications Market Size by Application (2017-2022)
8.3.2 Asia-Pacific OTC Anti-Infective Medications Market Size by Application (2023-2028)
8.3.3 Asia-Pacific OTC Anti-Infective Medications Market Share by Application (2017-2028)
8.4 Asia-Pacific OTC Anti-Infective Medications Market Size by Region
8.4.1 Asia-Pacific OTC Anti-Infective Medications Market Size by Region (2017-2022)
8.4.2 Asia-Pacific OTC Anti-Infective Medications Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America OTC Anti-Infective Medications Market Size (2017-2028)
9.2 Latin America OTC Anti-Infective Medications Market Size by Type
9.2.1 Latin America OTC Anti-Infective Medications Market Size by Type (2017-2022)
9.2.2 Latin America OTC Anti-Infective Medications Market Size by Type (2023-2028)
9.2.3 Latin America OTC Anti-Infective Medications Market Share by Type (2017-2028)
9.3 Latin America OTC Anti-Infective Medications Market Size by Application
9.3.1 Latin America OTC Anti-Infective Medications Market Size by Application (2017-2022)
9.3.2 Latin America OTC Anti-Infective Medications Market Size by Application (2023-2028)
9.3.3 Latin America OTC Anti-Infective Medications Market Share by Application (2017-2028)
9.4 Latin America OTC Anti-Infective Medications Market Size by Country
9.4.1 Latin America OTC Anti-Infective Medications Market Size by Country (2017-2022)
9.4.2 Latin America OTC Anti-Infective Medications Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Anti-Infective Medications Market Size (2017-2028)
10.2 Middle East & Africa OTC Anti-Infective Medications Market Size by Type
10.2.1 Middle East & Africa OTC Anti-Infective Medications Market Size by Type (2017-2022)
10.2.2 Middle East & Africa OTC Anti-Infective Medications Market Size by Type (2023-2028)
10.2.3 Middle East & Africa OTC Anti-Infective Medications Market Share by Type (2017-2028)
10.3 Middle East & Africa OTC Anti-Infective Medications Market Size by Application
10.3.1 Middle East & Africa OTC Anti-Infective Medications Market Size by Application (2017-2022)
10.3.2 Middle East & Africa OTC Anti-Infective Medications Market Size by Application (2023-2028)
10.3.3 Middle East & Africa OTC Anti-Infective Medications Market Share by Application (2017-2028)
10.4 Middle East & Africa OTC Anti-Infective Medications Market Size by Country
10.4.1 Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2017-2022)
10.4.2 Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline OTC Anti-Infective Medications Introduction
11.1.4 GlaxoSmithKline Revenue in OTC Anti-Infective Medications Business (2017-2022)
11.1.5 GlaxoSmithKline Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck OTC Anti-Infective Medications Introduction
11.2.4 Merck Revenue in OTC Anti-Infective Medications Business (2017-2022)
11.2.5 Merck Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer OTC Anti-Infective Medications Introduction
11.3.4 Pfizer Revenue in OTC Anti-Infective Medications Business (2017-2022)
11.3.5 Pfizer Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis OTC Anti-Infective Medications Introduction
11.4.4 Novartis Revenue in OTC Anti-Infective Medications Business (2017-2022)
11.4.5 Novartis Recent Developments
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott OTC Anti-Infective Medications Introduction
11.5.4 Abbott Revenue in OTC Anti-Infective Medications Business (2017-2022)
11.5.5 Abbott Recent Developments
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi OTC Anti-Infective Medications Introduction
11.6.4 Sanofi Revenue in OTC Anti-Infective Medications Business (2017-2022)
11.6.5 Sanofi Recent Developments
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb OTC Anti-Infective Medications Introduction
11.7.4 Bristol-Myers Squibb Revenue in OTC Anti-Infective Medications Business (2017-2022)
11.7.5 Bristol-Myers Squibb Recent Developments
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche OTC Anti-Infective Medications Introduction
11.8.4 Roche Revenue in OTC Anti-Infective Medications Business (2017-2022)
11.8.5 Roche Recent Developments
11.9 NanoViricides
11.9.1 NanoViricides Company Details
11.9.2 NanoViricides Business Overview
11.9.3 NanoViricides OTC Anti-Infective Medications Introduction
11.9.4 NanoViricides Revenue in OTC Anti-Infective Medications Business (2017-2022)
11.9.5 NanoViricides Recent Developments
11.10 Novabay Pharmaceuticals
11.10.1 Novabay Pharmaceuticals Company Details
11.10.2 Novabay Pharmaceuticals Business Overview
11.10.3 Novabay Pharmaceuticals OTC Anti-Infective Medications Introduction
11.10.4 Novabay Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2017-2022)
11.10.5 Novabay Pharmaceuticals Recent Developments
11.11 Optimer Pharmaceuticals
11.11.1 Optimer Pharmaceuticals Company Details
11.11.2 Optimer Pharmaceuticals Business Overview
11.11.3 Optimer Pharmaceuticals OTC Anti-Infective Medications Introduction
11.11.4 Optimer Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2017-2022)
11.11.5 Optimer Pharmaceuticals Recent Developments
11.12 Basilea Pharmaceutica
11.12.1 Basilea Pharmaceutica Company Details
11.12.2 Basilea Pharmaceutica Business Overview
11.12.3 Basilea Pharmaceutica OTC Anti-Infective Medications Introduction
11.12.4 Basilea Pharmaceutica Revenue in OTC Anti-Infective Medications Business (2017-2022)
11.12.5 Basilea Pharmaceutica Recent Developments
11.13 MerLion Pharma
11.13.1 MerLion Pharma Company Details
11.13.2 MerLion Pharma Business Overview
11.13.3 MerLion Pharma OTC Anti-Infective Medications Introduction
11.13.4 MerLion Pharma Revenue in OTC Anti-Infective Medications Business (2017-2022)
11.13.5 MerLion Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global OTC Anti-Infective Medications Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Antifungals
Table 3. Key Players of Antiseptic
Table 4. Key Players of Antiparasitics
Table 5. Global OTC Anti-Infective Medications Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global OTC Anti-Infective Medications Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global OTC Anti-Infective Medications Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global OTC Anti-Infective Medications Market Share by Region (2017-2022)
Table 9. Global OTC Anti-Infective Medications Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global OTC Anti-Infective Medications Market Share by Region (2023-2028)
Table 11. OTC Anti-Infective Medications Market Trends
Table 12. OTC Anti-Infective Medications Market Drivers
Table 13. OTC Anti-Infective Medications Market Challenges
Table 14. OTC Anti-Infective Medications Market Restraints
Table 15. Global OTC Anti-Infective Medications Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global OTC Anti-Infective Medications Revenue Share by Players (2017-2022)
Table 17. Global Top OTC Anti-Infective Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Medications as of 2021)
Table 18. Ranking of Global Top OTC Anti-Infective Medications Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by OTC Anti-Infective Medications Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players OTC Anti-Infective Medications Product Solution and Service
Table 22. Date of Enter into OTC Anti-Infective Medications Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global OTC Anti-Infective Medications Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global OTC Anti-Infective Medications Revenue Market Share by Type (2017-2022)
Table 26. Global OTC Anti-Infective Medications Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global OTC Anti-Infective Medications Revenue Market Share by Type (2023-2028)
Table 28. Global OTC Anti-Infective Medications Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global OTC Anti-Infective Medications Revenue Share by Application (2017-2022)
Table 30. Global OTC Anti-Infective Medications Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global OTC Anti-Infective Medications Revenue Share by Application (2023-2028)
Table 32. North America OTC Anti-Infective Medications Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America OTC Anti-Infective Medications Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America OTC Anti-Infective Medications Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America OTC Anti-Infective Medications Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America OTC Anti-Infective Medications Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America OTC Anti-Infective Medications Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe OTC Anti-Infective Medications Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe OTC Anti-Infective Medications Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe OTC Anti-Infective Medications Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe OTC Anti-Infective Medications Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe OTC Anti-Infective Medications Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe OTC Anti-Infective Medications Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific OTC Anti-Infective Medications Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific OTC Anti-Infective Medications Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific OTC Anti-Infective Medications Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific OTC Anti-Infective Medications Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific OTC Anti-Infective Medications Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific OTC Anti-Infective Medications Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America OTC Anti-Infective Medications Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America OTC Anti-Infective Medications Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America OTC Anti-Infective Medications Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America OTC Anti-Infective Medications Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America OTC Anti-Infective Medications Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America OTC Anti-Infective Medications Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa OTC Anti-Infective Medications Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa OTC Anti-Infective Medications Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa OTC Anti-Infective Medications Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa OTC Anti-Infective Medications Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa OTC Anti-Infective Medications Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa OTC Anti-Infective Medications Market Size by Country (2023-2028) & (US$ Million)
Table 62. GlaxoSmithKline Company Details
Table 63. GlaxoSmithKline Business Overview
Table 64. GlaxoSmithKline OTC Anti-Infective Medications Product
Table 65. GlaxoSmithKline Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
Table 66. GlaxoSmithKline Recent Developments
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck OTC Anti-Infective Medications Product
Table 70. Merck Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
Table 71. Merck Recent Developments
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer OTC Anti-Infective Medications Product
Table 75. Pfizer Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
Table 76. Pfizer Recent Developments
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis OTC Anti-Infective Medications Product
Table 80. Novartis Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
Table 81. Novartis Recent Developments
Table 82. Abbott Company Details
Table 83. Abbott Business Overview
Table 84. Abbott OTC Anti-Infective Medications Product
Table 85. Abbott Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
Table 86. Abbott Recent Developments
Table 87. Sanofi Company Details
Table 88. Sanofi Business Overview
Table 89. Sanofi OTC Anti-Infective Medications Product
Table 90. Sanofi Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
Table 91. Sanofi Recent Developments
Table 92. Bristol-Myers Squibb Company Details
Table 93. Bristol-Myers Squibb Business Overview
Table 94. Bristol-Myers Squibb OTC Anti-Infective Medications Product
Table 95. Bristol-Myers Squibb Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
Table 96. Bristol-Myers Squibb Recent Developments
Table 97. Roche Company Details
Table 98. Roche Business Overview
Table 99. Roche OTC Anti-Infective Medications Product
Table 100. Roche Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
Table 101. Roche Recent Developments
Table 102. NanoViricides Company Details
Table 103. NanoViricides Business Overview
Table 104. NanoViricides OTC Anti-Infective Medications Product
Table 105. NanoViricides Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
Table 106. NanoViricides Recent Developments
Table 107. Novabay Pharmaceuticals Company Details
Table 108. Novabay Pharmaceuticals Business Overview
Table 109. Novabay Pharmaceuticals OTC Anti-Infective Medications Product
Table 110. Novabay Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
Table 111. Novabay Pharmaceuticals Recent Developments
Table 112. Optimer Pharmaceuticals Company Details
Table 113. Optimer Pharmaceuticals Business Overview
Table 114. Optimer Pharmaceuticals OTC Anti-Infective Medications Product
Table 115. Optimer Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
Table 116. Optimer Pharmaceuticals Recent Developments
Table 117. Basilea Pharmaceutica Company Details
Table 118. Basilea Pharmaceutica Business Overview
Table 119. Basilea Pharmaceutica OTC Anti-Infective Medications Product
Table 120. Basilea Pharmaceutica Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
Table 121. Basilea Pharmaceutica Recent Developments
Table 122. MerLion Pharma Company Details
Table 123. MerLion Pharma Business Overview
Table 124. MerLion Pharma OTC Anti-Infective Medications Product
Table 125. MerLion Pharma Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
Table 126. MerLion Pharma Recent Developments
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global OTC Anti-Infective Medications Market Share by Type: 2021 VS 2028
Figure 2. Antifungals Features
Figure 3. Antiseptic Features
Figure 4. Antiparasitics Features
Figure 5. Global OTC Anti-Infective Medications Market Share by Application: 2021 VS 2028
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Drug Stores Case Studies
Figure 8. E-Commerce Case Studies
Figure 9. OTC Anti-Infective Medications Report Years Considered
Figure 10. Global OTC Anti-Infective Medications Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global OTC Anti-Infective Medications Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global OTC Anti-Infective Medications Market Share by Region: 2021 VS 2028
Figure 13. Global OTC Anti-Infective Medications Market Share by Players in 2021
Figure 14. Global Top OTC Anti-Infective Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Medications as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by OTC Anti-Infective Medications Revenue in 2021
Figure 16. North America OTC Anti-Infective Medications Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America OTC Anti-Infective Medications Market Size Market Share by Type (2017-2028)
Figure 18. North America OTC Anti-Infective Medications Market Size Market Share by Application (2017-2028)
Figure 19. North America OTC Anti-Infective Medications Market Size Share by Country (2017-2028)
Figure 20. United States OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe OTC Anti-Infective Medications Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe OTC Anti-Infective Medications Market Size Market Share by Type (2017-2028)
Figure 24. Europe OTC Anti-Infective Medications Market Size Market Share by Application (2017-2028)
Figure 25. Europe OTC Anti-Infective Medications Market Size Share by Country (2017-2028)
Figure 26. Germany OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific OTC Anti-Infective Medications Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific OTC Anti-Infective Medications Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific OTC Anti-Infective Medications Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific OTC Anti-Infective Medications Market Size Share by Region (2017-2028)
Figure 36. China OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America OTC Anti-Infective Medications Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America OTC Anti-Infective Medications Market Size Market Share by Type (2017-2028)
Figure 44. Latin America OTC Anti-Infective Medications Market Size Market Share by Application (2017-2028)
Figure 45. Latin America OTC Anti-Infective Medications Market Size Share by Country (2017-2028)
Figure 46. Mexico OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa OTC Anti-Infective Medications Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa OTC Anti-Infective Medications Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa OTC Anti-Infective Medications Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa OTC Anti-Infective Medications Market Size Share by Country (2017-2028)
Figure 52. Turkey OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. GlaxoSmithKline Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
Figure 56. Merck Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
Figure 57. Pfizer Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
Figure 58. Novartis Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
Figure 59. Abbott Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
Figure 60. Sanofi Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
Figure 61. Bristol-Myers Squibb Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
Figure 62. Roche Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
Figure 63. NanoViricides Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
Figure 64. Novabay Pharmaceuticals Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
Figure 65. Optimer Pharmaceuticals Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
Figure 66. Basilea Pharmaceutica Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
Figure 67. MerLion Pharma Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Industry Market Size
